Head-to-head evaluation of the antiepileptic drugs levetiracetam (LEV) vs. sulthiame (STM) in a German multi-centre, doubleblind controlled trial in children with benign epilepsy with centro-temporal spikes.

Trial Profile

Head-to-head evaluation of the antiepileptic drugs levetiracetam (LEV) vs. sulthiame (STM) in a German multi-centre, doubleblind controlled trial in children with benign epilepsy with centro-temporal spikes.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 04 Dec 2012

At a glance

  • Drugs Levetiracetam; Sultiame
  • Indications Epilepsy
  • Focus Therapeutic Use
  • Acronyms HEAD-STUDIE
  • Most Recent Events

    • 12 Jul 2011 Additional lead trial centre identified as reported by European Clinical Trials Database.
    • 12 Jul 2011 New source identified and integrated (European Clinical Trials Database; EudraCT2005-004468-22).
    • 10 Feb 2009 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top